Oscar Health (OSCR) Is Up 17.4% After Swinging To Profit And Raising 2026 Guidance - What's Changed

Simply Wall St.08-16

In early August 2026, Oscar Health, Inc. reported that it moved from a net loss to net income of US$361.81 million in the second quarter and US$1.04 billion for the first half, with earnings per share...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2659177502?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/7212000-choice1-main-header/1585186806799","is_english":true,"pubTime":"2026-08-16 21:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2659177502","market":"nz","top_or_hot":-1,"title":"Oscar Health (OSCR) Is Up 17.4% After Swinging To Profit And Raising 2026 Guidance - What's Changed","media":"Simply Wall St.","content":"<div>\n<p>In early August 2026, Oscar Health, Inc. reported that it moved from a net loss to net income of US$361.81 million in the second quarter and US$1.04 billion for the first half, with earnings per share...</p>\n\n<a href=\"https://simplywall.st/stocks/us/insurance/nyse-oscr/oscar-health/news/oscar-health-oscr-is-up-174-after-swinging-to-profit-and-rai\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oscar Health (OSCR) Is Up 17.4% After Swinging To Profit And Raising 2026 Guidance - What's Changed</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOscar Health (OSCR) Is Up 17.4% After Swinging To Profit And Raising 2026 Guidance - What's Changed\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-16 21:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/insurance/nyse-oscr/oscar-health/news/oscar-health-oscr-is-up-174-after-swinging-to-profit-and-rai><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In early August 2026, Oscar Health, Inc. reported that it moved from a net loss to net income of US$361.81 million in the second quarter and US$1.04 billion for the first half, with earnings per share...</p>\n\n<a href=\"https://simplywall.st/stocks/us/insurance/nyse-oscr/oscar-health/news/oscar-health-oscr-is-up-174-after-swinging-to-profit-and-rai\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4162","symbol_name":"人寿与健康保险","start_time":0,"source_url":"https://simplywall.st/stocks/us/insurance/nyse-oscr/oscar-health/news/oscar-health-oscr-is-up-174-after-swinging-to-profit-and-rai","article_id":"2659177502","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/7212000-choice1-main-header/1585186806799"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/insurance/nyse-oscr/oscar-health/news/oscar-health-oscr-is-up-174-after-swinging-to-profit-and-rai","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2659177502","pubTimestamp":1786886436,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"In early August 2026, Oscar Health, Inc. reported that it moved from a net loss to net income of US$361.81 million in the second quarter and US$1.04 billion for the first half, with earnings per share turning positive on both a basic and diluted basis.\nAlongside this shift to profitability, Oscar Health raised its 2026 guidance for total revenue to US$18.7–US$19.0 billion and for earnings from operations to US$500–US$700 million, underscoring how pricing discipline and technology-driven...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4162":"人寿与健康保险","BK4551":"寇图资本持仓","OSCR":"Oscar Health, Inc.","OSCG":"2倍做多OSCR ETF-Leverage Shares","OSCX":"2倍做多OSCR ETF-Defiance","HEAL":"Global X HealthTech ETF"},"translate_title":"Oscar Health (OSCR) 在扭亏为盈并上调 2026 年指引后上涨 17.4% - 发生了什么变化","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OSCR":1.98,"OSCG":0.6,"HEAL":0.6,"OSCX":0.6},"content_text":"In early August 2026, Oscar Health, Inc. reported that it moved from a net loss to net income of US$361.81 million in the second quarter and US$1.04 billion for the first half, with earnings per share turning positive on both a basic and diluted basis. Alongside this shift to profitability, Oscar Health raised its 2026 guidance for total revenue to US$18.7–US$19.0 billion and for earnings from operations to US$500–US$700 million, underscoring how pricing discipline and technology-driven efficiencies are reshaping its financial profile. Now we’ll examine how Oscar Health’s upgraded 2026 earnings from operations guidance could influence its previously cautious investment narrative. Invest in the nuclear renaissance through our list of 92 elite nuclear energy infrastructure plays powering the global AI revolution.AdvertisementOscar Health Investment Narrative RecapTo own Oscar Health today, you need to believe its technology, pricing discipline, and ACA-focused model can sustain profitable growth while keeping medical costs under control. The key near term catalyst is whether the company can deliver on its sharply higher 2026 operating earnings guidance, while the biggest current risk is that utilization, risk adjustment, or churn pressures could erode margins again. The latest results and guidance upgrade directly sharpen both the opportunity and that risk. The most relevant update is Oscar Health’s decision on 6 August 2026 to nearly double its 2026 earnings from operations guidance to US$500–US$700 million, while reaffirming revenue of US$18.7–US$19.0 billion. For anyone watching catalysts, this raises the bar for execution on pricing, cost control, and membership quality, making each upcoming quarter a more important test of whether the recent profitability can hold up under real world medical cost trends. Yet against this stronger outlook, the risk that medical costs, risk adjustment, and churn could again pressure margins is something investors should be aware of as they consider... Read the full narrative on Oscar Health (it's free!)Oscar Health's narrative projects $23.8 billion revenue and $998.5 million earnings by 2029. This requires 21.4% yearly revenue growth and about a $1.0 billion earnings increase from -$39.4 million today.Uncover how Oscar Health's forecasts yield a $24.20 fair value, a 26% downside to its current price.Exploring Other PerspectivesOSCR 1-Year Stock Price Chart Some of the lowest ranked analysts were already cautious, assuming only about US$18.9 billion of revenue and US$813.7 million of earnings by 2029, so this latest profitability surprise may force a rethink of both their downside risks and upside catalysts.Explore 8 other fair value estimates on Oscar Health - why the stock might be a potential multi-bagger!Form Your Own VerdictDisagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.A great starting point for your Oscar Health research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.Our free Oscar Health research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Oscar Health's overall financial health at a glance.Want Some Alternatives?These stocks are moving-our analysis flagged them today. Act fast before the price catches up:The future of work is here. Discover the 37 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.Explore 24 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.AI is about to change healthcare. These 42 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"2","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2659177502","isCrawlerRequest":true}